Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2023-10-25 00:00:00 ET · period of report 2023-10-20 · accession 0001140361-23-049426 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-25 | 2023-10-20 | RCKT | Militello John | See Remarks | S - Sale | $17.06 | -564 | 8,760 | -6% | -$9,622 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-20 | S | D | 564 | $17.06 | 8,760 | D | — | — |